1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Extended treatment with adjuvant imatinib (IM) for patients (pts) with high-risk primary gastrointestinal stromal tumor (GIST): The PERSIST-5 study
    Meeting Abstract

    Raut, C. P.; Espat, N. J.; Maki, R. G.; Araujo, D. M.; Williams, T. F.; Wolff, J. E.; DeMatteo, R. P.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Analysis of outcomes in metastatic pancreatic cancer: Real-world experience in academic cancer centers
    Meeting Abstract

    Popa, E. C.; Rabinovich, E.; Sohal, D.; Arbour, K. C.; Kim, T. S.; Lu, Y.; Christos, P. J.; Khorana, A. A.; Shah, M. A.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) in pancreatic neuroendocrine tumors (panNETs): Defining differentiation and grade genetically
    Meeting Abstract

    Raj, N. P.; Klimstra, D.; Shah, R.; Osoba, M.; Alexander, D.; Reidy, D. L.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Performance of a high-intensity 508-gene circulating-tumor DNA (ctDNA) assay in patients with metastatic breast, lung, and prostate cancer
    Meeting Abstract

    Razavi, P.; Li, B.; Abida, W.; Aravanis, A.; Jung, B.; Shen, R.; Hou, C.; De Bruijn, I.; Gnerre, S.; Lim, R. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or without androgen deprivation therapy for unfavorable-risk prostate cancer
    Meeting Abstract

    Patel, S. A.; Chen, M. H.; Loffredo, M.; Renshaw, A. A.; Kantoff, P. W.; D'Amico, A. V.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Prospective development of a patient reported outcomes (PRO) tool in desmoid tumors: A novel clinical trial endpoint
    Meeting Abstract

    Paty, J.; Maddux, L.; Gounder, M. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Association of liver metastases (LM) with survival in NSCLC patients treated with durvalumab (D) in two independent clinical trials
    Meeting Abstract

    Paz-Ares, L. G.; Shen, K.; Higgs, B. W.; Morehouse, C.; Rizvi, N. A.; Segal, N. H.; Jin, X.; Zheng, Y.; Narwal, R.; Gupta, A. K.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical and molecular landscape of metastatic colorectal cancer (mCRC) harboring ALK, ROS1, or NTRK 1, 2, 3 (NTRKs) rearrangements
    Meeting Abstract

    Pietrantonio, F.; Di Nicolantonio, F.; Schrock, A. B.; Lee, J.; Tejpar, S.; Siena, S.; Christiansen, J. H.; Hechtman, J. F.; Fucà, G.; Antoniotti, C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer
    Meeting Abstract

    Park, J. J.; Hajj, C.; Reyngold, M.; Shi, W.; Zhang, Z.; Cuaron, J. J.; Crane, C. H.; O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I study of enfortumab vedotin (ASG-22CE; ASG-22ME): Updated analysis of patients with metastatic urothelial cancer
    Meeting Abstract

    Petrylak, D. P.; Perez, R. P.; Zhang, J.; Smith, D. C.; Ruether, J. D.; Sridhar, S. S.; Sangha, R. S.; Lang, J. M.; Heath, E. I.; Merchan, J. R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save